Assessing Handwriting Skills in Adults with Autism
Analysis on Graphic Tablet of Motor and Cognitive Components of Written Production in Adults With and Without Autism Spectrum Disorder
NA · Centre Hospitalier de Niort · NCT06304701
This study is testing how well adults with autism can write and what challenges they face in their writing skills.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 38 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier de Niort (other) |
| Locations | 1 site (Niort) |
| Trial ID | NCT06304701 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the psycholinguistic and graphomotor characteristics of written production in adults diagnosed with Autism Spectrum Disorder (ASD). It will assess the quantity and quality of written output through various tasks, including text copying and descriptive and persuasive writing. The study will also explore the relationship between specific deficits associated with ASD and challenges in writing, as well as the correlation between the severity of ASD and writing difficulties. Participants will undergo cognitive and writing tests to gather comprehensive data on their writing abilities.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have a diagnosis of Autism Spectrum Disorder according to DSM-5 criteria.
Not a fit: Patients with other neurodevelopmental disorders or those who do not meet the ASD criteria may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of writing difficulties in adults with ASD, leading to improved educational and therapeutic strategies.
How similar studies have performed: While studies on writing skills in ASD exist, this specific focus on adult handwriting characteristics is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria for experimental group only: * ASD diagnosis according to DSM-5 criteria and established by an interdisciplinary Inclusion Criteria for both experimental and control groups: * Age ≥ 18 years Age ≥ 18 years and matching typical adult subjects to ASD individuals in age (plus or minus 5 years), sex, and education level * The person participating in the research has read, understood, and signed the study consent form * The person is proficient in the French language * The person is affiliated with a social security system Exclusion Criteria for experimental group only: * Diagnosis of any other NDD than ASD (e.g., Attention Deficit Hyperactivity Disorder, Specific Learning Disorder, Language Disorder, Coordination Disorder, Intellectual Disorder) Exclusion Criteria for control group only: - Diagnosis of any NDD (ASD, Attention Deficit Hyperactivity Disorder, Specific Learning Disorder, Language Disorder, Coordination Disorder, Intellectual Disorder) Exclusion Criteria for both experimental and control groups: * Refusal of the individual to participate in the study * Presence of severe visual impairment * Known pregnancy * Individual deprived of liberty * Individual under guardianship or curators * Presence of concurrent psychotropic medication treatments not stabilized, initiated within the last 2 months: antipsychotics, mood stabilizers, antiepileptics, psychostimulants, antidepressants * Presence of upper limb motor impairment, with or without devices * Presence of diagnosed neurological or psychiatric disorders (e.g., Schizophrenia Spectrum Disorder or other psychotic disorders), presence of a general or metabolic pathology known to have an impact on cognitive efficiency and/or motor skills of the individual (e.g., Epilepsy, Tics and Tourette Syndrome, Neuro-muscular Syndrome, Metabolic Neurological Syndromes, neoplasms)
Where this trial is running
Niort
- Centre Hospitalier de Niort — Niort, France (RECRUITING)
Study contacts
- Principal investigator: Evan E Launay, Mr — Hospital Center of Niort (France)
- Study coordinator: Evan E Launay, Mr
- Email: evan.launay@ch-niort.fr
- Phone: +33549783846
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Autism Spectrum Disorder, Written production, Handwriting, Graphomotor skills, Language, Graphic tablet